Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.240
-0.050 (-2.18%)
At close: Apr 29, 2026, 4:00 PM EDT
2.281
+0.040 (1.81%)
After-hours: Apr 29, 2026, 5:28 PM EDT
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or -90.48% compared to the previous year.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$955,676
Market Cap
35.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 20 | -190 | -90.48% | 20 | 0 |
| Sep 30, 2024 | 210 | 21 | 11.11% | 210 | 0 |
| Sep 30, 2023 | 189 | -44 | -18.88% | 189 | 0 |
| Sep 30, 2022 | 233 | -19 | -7.54% | 233 | 0 |
| Sep 30, 2021 | 252 | -87 | -25.66% | 252 | 0 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| Werewolf Therapeutics | 39 |
| Cue Biopharma | 29 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| RenovoRx | 17 |
VERU News
- 7 weeks ago - Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - GlobeNewsWire
- 2 months ago - Veru Inc. Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Veru Inc. Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th - GlobeNewsWire
- 4 months ago - Veru Inc. Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - GlobeNewsWire
- 5 months ago - Veru to Report Fiscal Year 2025 Financial Results on December 17th - GlobeNewsWire
- 6 months ago - Veru to Present Two Abstracts at ObesityWeek 2025 - GlobeNewsWire